1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Pharmaceutical & Biopharmaceutical Contract
Manufacturing Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Sector (Pharmaceutical, Biopharmaceutical)
5.2.2. By Product Type
(Active Pharmaceutical Ingredients (API), Finished Dosage, Formulation Advanced
Drug Delivery Products, Over the Counter (OTC) Medicines, Nutritional Products,
Others)
5.2.2.1.
By Finished Dosage (Tablet, Capsule, Oral Liquids,
Parenteral/Injectables, Others)
5.2.3. By Service (Pharmaceutical
Manufacturing Services, Biologics Manufacturing Services, Drug Development
Services)
5.2.3.1.
By Pharmaceutical Manufacturing services (Pharmaceutical
API Manufacturing Services, Pharmaceutical FDF Manufacturing Services)
5.2.3.2.
By Biologics Manufacturing Services (Biologics FDF
Manufacturing Services, Biologics API Manufacturing Services)
5.2.4. By Drug Type (Originator / Patented, Generics, Biosimilar)
5.2.5. By Company (2022)
5.2.6. By Region
5.3. Market Attractiveness Index
6.
Asia-Pacific Pharmaceutical & Biopharmaceutical
Contract Manufacturing Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Sector
6.2.2. By Product Type
6.2.3. By Service
6.2.4. By Drug Type
6.2.5. By Country
6.3.
Competition Outlook
6.4.
Asia-Pacific: Country Analysis
6.4.1. China Pharmaceutical
& Biopharmaceutical Contract Manufacturing Market Outlook
6.4.1.1.
Market Size & Forecast
6.4.1.1.1.
By Value
6.4.1.2.
Market Share & Forecast
6.4.1.2.1.
By Sector
6.4.1.2.2.
By Product Type
6.4.1.2.3.
By Service
6.4.1.2.4.
By Drug Type
6.4.2. India Pharmaceutical
& Biopharmaceutical Contract Manufacturing Market Outlook
6.4.2.1.
Market Size & Forecast
6.4.2.1.1.
By Value
6.4.2.2.
Market Share & Forecast
6.4.2.2.1.
By Sector
6.4.2.2.2.
By Product Type
6.4.2.2.3.
By Service
6.4.2.2.4.
By Drug Type
6.4.3. Japan Pharmaceutical
& Biopharmaceutical Contract Manufacturing Market Outlook
6.4.3.1.
Market Size & Forecast
6.4.3.1.1.
By Value
6.4.3.2.
Market Share & Forecast
6.4.3.2.1.
By Sector
6.4.3.2.2.
By Product Type
6.4.3.2.3.
By Service
6.4.3.2.4.
By Drug Type
6.4.4. South Korea Pharmaceutical
Contract Manufacturing Market Outlook
6.4.4.1.
Market Size & Forecast
6.4.4.1.1.
By Value
6.4.4.2.
Market Share & Forecast
6.4.4.2.1.
By Sector
6.4.4.2.2.
By Product Type
6.4.4.2.3.
By Service
6.4.4.2.4.
By Drug Type
6.4.5. Australia
Pharmaceutical Contract Manufacturing Market Outlook
6.4.5.1.
Market Size & Forecast
6.4.5.1.1.
By Value
6.4.5.2.
Market Share & Forecast
6.4.5.2.1.
By Sector
6.4.5.2.2.
By Product Type
6.4.5.2.3.
By Service
6.4.5.2.4.
By Drug Type
6.4.6. Singapore
Pharmaceutical Contract Manufacturing Market Outlook
6.4.6.1.
Market Size & Forecast
6.4.6.1.1.
By Value
6.4.6.2.
Market Share & Forecast
6.4.6.2.1.
By Sector
6.4.6.2.2.
By Product Type
6.4.6.2.3.
By Service
6.4.6.2.4.
By Drug Type
7.
Europe Pharmaceutical Contract Manufacturing Market
Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Sector
7.2.2. By Product Type
7.2.3. By Service
7.2.4. By Drug Type
7.2.5. By Country
7.3.
Competition Outlook
7.4.
Europe: Country Analysis
7.4.1. France Pharmaceutical
Contract Manufacturing Market Outlook
7.4.1.1.
Market Size & Forecast
7.4.1.1.1.
By Value
7.4.1.2.
Market Share & Forecast
7.4.1.2.1.
By Sector
7.4.1.2.2.
By Product Type
7.4.1.2.3.
By Service
7.4.1.2.4.
By Drug Type
7.4.2. Germany
Pharmaceutical Contract Manufacturing Market Outlook
7.4.2.1.
Market Size & Forecast
7.4.2.1.1.
By Value
7.4.2.2.
Market Share & Forecast
7.4.2.2.1.
By Sector
7.4.2.2.2.
By Product Type
7.4.2.2.3.
By Service
7.4.2.2.4.
By Drug Type
7.4.3. United Kingdom
Pharmaceutical Contract Manufacturing Market Outlook
7.4.3.1.
Market Size & Forecast
7.4.3.1.1.
By Value
7.4.3.2.
Market Share & Forecast
7.4.3.2.1.
By Sector
7.4.3.2.2.
By Product Type
7.4.3.2.3.
By Service
7.4.3.2.4.
By Drug Type
7.4.4. Italy Pharmaceutical
Contract Manufacturing Market Outlook
7.4.4.1.
Market Size & Forecast
7.4.4.1.1.
By Value
7.4.4.2.
Market Share & Forecast
7.4.4.2.1.
By Sector
7.4.4.2.2.
By Product Type
7.4.4.2.3.
By Service
7.4.4.2.4.
By Drug Type
7.4.5. Spain Pharmaceutical
Contract Manufacturing Market Outlook
7.4.5.1.
Market Size & Forecast
7.4.5.1.1.
By Value
7.4.5.2.
Market Share & Forecast
7.4.5.2.1.
By Sector
7.4.5.2.2.
By Product Type
7.4.5.2.3.
By Service
7.4.5.2.4.
By Drug Type
8.
North America Pharmaceutical Contract Manufacturing
Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Sector
8.2.2. By Product Type
8.2.3. By Service
8.2.4. By Drug Type
8.2.5. By Country
8.3.
Competition Outlook
8.4.
North America: Country Analysis
8.4.1. United States Pharmaceutical
Contract Manufacturing Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Product Type
8.4.1.2.2.
By Service
8.4.1.2.3.
By Application
8.4.1.2.4.
By End User
8.4.2. Mexico Pharmaceutical
Contract Manufacturing Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Sector
8.4.2.2.2.
By Product Type
8.4.2.2.3.
By Service
8.4.2.2.4.
By Drug Type
8.4.3. Canada Pharmaceutical
Contract Manufacturing Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Sector
8.4.3.2.2.
By Product Type
8.4.3.2.3.
By Service
8.4.3.2.4.
By Drug Type
9.
South America Pharmaceutical Contract Manufacturing
Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Sector
9.2.2. By Product Type
9.2.3. By Service
9.2.4. By Drug Type
9.2.5. By Country
9.3.
Competition Outlook
9.4.
South America: Country Analysis
9.4.1. Brazil Pharmaceutical
Contract Manufacturing Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Sector
9.4.1.2.2.
By Product Type
9.4.1.2.3.
By Service
9.4.1.2.4.
By Drug Type
9.4.2. Argentina Pharmaceutical
Contract Manufacturing Market Outlook
9.4.2.1.
Market Size & Forecast
9.4.2.1.1.
By Value
9.4.2.2.
Market Share & Forecast
9.4.2.2.1.
By Sector
9.4.2.2.2.
By Product Type
9.4.2.2.3.
By Service
9.4.2.2.4.
By Drug Type
9.4.3. Colombia
Pharmaceutical Contract Manufacturing Market Outlook
9.4.3.1.
Market Size & Forecast
9.4.3.1.1.
By Value
9.4.3.2.
Market Share & Forecast
9.4.3.2.1.
By Sector
9.4.3.2.2.
By Product Type
9.4.3.2.3.
By Service
9.4.3.2.4.
By Drug Type
10.
Middle East and Africa Pharmaceutical Contract
Manufacturing Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Sector
10.2.2. By Product Type
10.2.3. By Service
10.2.4. By Drug Type
10.2.5. By Country
10.3.
Competition Outlook
10.4.
MEA: Country Analysis
10.4.1. South Africa
Pharmaceutical Contract Manufacturing Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1.
By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1.
By Sector
10.4.1.2.2.
By Product Type
10.4.1.2.3.
By Service
10.4.1.2.4.
By Drug Type
10.4.2. Saudi Arabia Pharmaceutical
Contract Manufacturing Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1.
By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1.
By Sector
10.4.2.2.2.
By Product Type
10.4.2.2.3.
By Service
10.4.2.2.4.
By Drug Type
10.4.3. UAE Pharmaceutical
Contract Manufacturing Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1.
By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1.
By Sector
10.4.3.2.2.
By Product Type
10.4.3.2.3.
By Service
10.4.3.2.4.
By Drug Type
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
13.
Competitive Landscape
13.1.
Competition Outlook
13.2.
Players Profiled (Leading Companies)
13.2.1.
Jubilant Pharmova Limited
13.2.2.
JRS PHARMA GmbH & Co.
13.2.3. Boehringer Ingelheim GmbH
13.2.4. Lonza Group
13.2.5. Rentschler Biotechnologie GmbH
13.2.6. Inno Biologics Sdn Bhd
13.2.7.
INCOG BioPharma Services
13.2.8.
Baxter Biopharma Solutions
13.2.9.
Catalent Pharma Solutions
13.2.10.
Kemwell Biopharma Private Limited
14. Strategic Recommendations